- Home
- NG vs ALVO Comparison
NG vs ALVO Comparison
Compare NG & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NG | ALVO |
|---|---|---|
| Founded | 1984 | 2013 |
| Country | Canada | Luxembourg |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NG | ALVO |
|---|---|---|
| Price | $9.85 | $5.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $10.17 | $9.25 |
| AVG Volume (30 Days) | ★ 2.7M | 544.5K |
| Earning Date | 01-22-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $573,350,000.00 |
| Revenue This Year | N/A | $20.97 |
| Revenue Next Year | N/A | $43.04 |
| P/E Ratio | ★ N/A | $23.19 |
| Revenue Growth | N/A | ★ 45.55 |
| 52 Week Low | $2.26 | $4.32 |
| 52 Week High | $10.90 | $13.70 |
Technical Indicators
Market Signals| Indicator | NG | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 60.49 | 46.54 |
| Support Level | $9.43 | $5.40 |
| Resistance Level | $10.02 | $5.85 |
| Average True Range (ATR) | 0.43 | 0.31 |
| MACD | -0.01 | 0.15 |
| Stochastic Oscillator | 64.82 | 73.86 |
Price Performance
Historical ComparisonAbout NG Novagold Resources Inc.
Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other presious metals.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.